• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I 型前胶原氨基端前肽作为多发性骨髓瘤的一个潜在标志物。

Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.

机构信息

Department of Tumor Markers, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre ul. W.K. Roentgena 5, 02-781 Warszawa, Poland.

出版信息

Clin Biochem. 2010 Apr;43(6):604-8. doi: 10.1016/j.clinbiochem.2009.12.018. Epub 2010 Jan 4.

DOI:10.1016/j.clinbiochem.2009.12.018
PMID:20045402
Abstract

OBJECTIVES

Investigating relationship between bone markers, cytokines and conventional prognostic parameters in patients with multiple myeloma (MM) and to assess the clinical application of bone turnover markers.

DESIGN AND METHODS

Sixty-four patients with MM were examined before treatment and followed for survival for over 7 years. Serum concentrations of bone markers and cytokines were determined by the Roche and R&D kits, respectively. Standard deviation scores (SDS) were employed to normalize values.

RESULTS

Collagen fragments (beta-CTX) were elevated in 47%, procollagen I amino-terminal propeptide (PINP)-in 28%, and osteocalcin (OC) in 11% of patients. The values of the SDS of PINP and OC, but not beta-CTX significantly decreased with MM stage. beta-CTX inversely correlated with vascular endothelial growth factor (VEGF) and albumin, and directly correlated with serum macrophage colony-stimulating factor (M-CSF). OC values correlated with albumin and beta2-microglobulin. PINP inversely correlated with LDH. The SDS values of PINP were significantly lower in MM patients with advanced bone disease.

CONCLUSIONS

Circulating PINP concentration may be a useful marker for monitoring of treatment of multiple myeloma patients with bone lytic lesions, in particular, of patients treated with preoteasome inhibitors.

摘要

目的

研究多发性骨髓瘤(MM)患者骨标志物、细胞因子与常规预后参数之间的关系,并评估骨转换标志物的临床应用。

方法

对 64 例 MM 患者进行治疗前检查,并进行了超过 7 年的生存随访。采用罗氏和 R&D 试剂盒分别检测血清骨标志物和细胞因子浓度。采用标准偏差评分(SDS)对数值进行归一化。

结果

47%的患者胶原片段(β-CTX)升高,28%的患者前胶原 I 氨基端前肽(PINP)升高,11%的患者骨钙素(OC)升高。PINP 和 OC 的 SDS 值随着 MM 分期的增加而显著降低,但β-CTX 则相反。β-CTX 与血管内皮生长因子(VEGF)和白蛋白呈负相关,与血清巨噬细胞集落刺激因子(M-CSF)呈正相关。OC 值与白蛋白和β2-微球蛋白相关。PINP 的 SDS 值在有进展性骨病的 MM 患者中显著降低。

结论

循环 PINP 浓度可能是监测多发性骨髓瘤患者溶骨性病变治疗的有用标志物,特别是接受蛋白酶体抑制剂治疗的患者。

相似文献

1
Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.I 型前胶原氨基端前肽作为多发性骨髓瘤的一个潜在标志物。
Clin Biochem. 2010 Apr;43(6):604-8. doi: 10.1016/j.clinbiochem.2009.12.018. Epub 2010 Jan 4.
2
The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.I型胶原的氨基端前肽(PINP)是骨转移乳腺癌中骨转换和转移扩散程度的临床有效指标。
Anticancer Res. 2007 Jul-Aug;27(4A):1853-62.
3
Type I collagen metabolites as tumor markers in patients with lung carcinoma.I型胶原代谢产物作为肺癌患者的肿瘤标志物
Cancer. 1999 May 1;85(9):1951-7.
4
How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.骨转换标志物在类风湿关节炎中有多大作用?疾病活动度和皮质类固醇治疗的影响。
Rev Rhum Engl Ed. 1997 Mar;64(3):153-9.
5
Effect of age-related chronic immobility on markers of bone turnover.年龄相关的长期不活动对骨转换标志物的影响。
J Bone Miner Res. 2006 Feb;21(2):324-31. doi: 10.1359/JBMR.051014. Epub 2005 Oct 24.
6
High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.高血清胰岛素样生长因子结合蛋白-2可预测老年男性和女性骨转换增加。
J Bone Miner Res. 2007 Jun;22(6):799-807. doi: 10.1359/jbmr.070306.
7
Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.骨形成中的代谢间隙可能是监测前列腺癌骨转移的一种新标志物。
J Urol. 2002 Apr;167(4):1863-6.
8
Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.血清I型胶原羧基末端肽(ICTP)以及I型前胶原羧基末端和氨基末端前肽(PICP、PINP)的浓度作为乳腺癌转移性骨病的标志物。
Anticancer Res. 1996 Jul-Aug;16(4B):2289-93.
9
Cross-sectional evaluation of bone metabolism in men.男性骨代谢的横断面评估。
J Bone Miner Res. 2001 Sep;16(9):1642-50. doi: 10.1359/jbmr.2001.16.9.1642.
10
Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.多发性骨髓瘤患者血清肝细胞生长因子浓度升高:与疾病活动标志物的相关性
Am J Hematol. 2003 Apr;72(4):229-33. doi: 10.1002/ajh.10304.

引用本文的文献

1
Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.补体C3a通过抑制Sirt1激活多发性骨髓瘤患者的PI3K/PDK1/SGK3途径来促进破骨细胞的形成。
J Transl Med. 2025 Mar 16;23(1):338. doi: 10.1186/s12967-025-06319-3.
2
The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients.初诊多发性骨髓瘤患者血清骨代谢指标与骨病及生存的相关性。
Cancer Biol Ther. 2024 Dec 31;25(1):2403205. doi: 10.1080/15384047.2024.2403205. Epub 2024 Sep 18.
3
The numerous facets of 1q21 in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review).
1q21在多发性骨髓瘤中的多方面研究:发病机制、临床病理特征、预后及临床进展(综述)
Oncol Lett. 2024 Apr 9;27(6):258. doi: 10.3892/ol.2024.14391. eCollection 2024 Jun.
4
Deficient invariant natural killer T cells had impaired regulation on osteoclastogenesis in myeloma bone disease.骨髓瘤骨病中,固有自然杀伤 T 细胞缺陷会损害破骨细胞生成的调节。
J Cell Mol Med. 2018 May;22(5):2706-2716. doi: 10.1111/jcmm.13554. Epub 2018 Feb 23.
5
Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.CTX-I 和 PINP 作为骨转换标志物的应用:国家骨健康联盟建议规范样本处理和患者准备,以减少分析前的变异性。
Osteoporos Int. 2017 Sep;28(9):2541-2556. doi: 10.1007/s00198-017-4082-4. Epub 2017 Jun 19.